Ifp Advisors, Inc Relay Therapeutics, Inc. Transaction History
Ifp Advisors, Inc
- $3.28 Billion
- Q2 2025
A detailed history of Ifp Advisors, Inc transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 169 shares of RLAY stock, worth $1,022. This represents 0.0% of its overall portfolio holdings.
Number of Shares
169
Previous 0
Infinity%
Holding current value
$1,022
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RLAY
# of Institutions
211Shares Held
168MCall Options Held
0Put Options Held
36.1K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$169 Million0.77% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct13.4MShares$81.3 Million0.1% of portfolio
-
Commodore Capital LP New York, NY13.4MShares$80.8 Million4.31% of portfolio
-
Casdin Capital, LLC New York, NY11.4MShares$69 Million5.53% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$63.8 Million0.0% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $727M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...